DNA
NYSEStockGinkgo Bioworks Holdings, Inc.
$6.37-0.47 (-6.81%)
52-Week Range
$5.57
$16.14
Key Stats
Market Cap
394.5M
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.59
Volume
1.5M
Avg Volume
1.4M
Performance
1M
-30.66%
3M
-31.48%
6M
-37.68%
YTD
-26.44%
1Y
-3.76%
3Y
-88.15%
5Y
-98.69%
Price Chart
ETF Exposure
DNA is held by 49 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| EATV | VegTech Plant-based Innovation & Climate ETF | 3.67% |
| LOPX | Direxion Low Priced Stock ETF | 2.42% |
| SPXZ | Morgan Creek - Exos SPAC Originated ETF | 0.88% |
| MRND | IQ U.S. Mid Cap R&D Leaders ETF | 0.62% |
| WDNA | WisdomTree BioRevolution Fund | 0.59% |
| IDNA | iShares Genomics Immunology and Healthcare ETF | 0.28% |
| TRFM | AAM Transformers ETF | 0.24% |
| ISMD | Inspire Small/Mid Cap ETF | 0.15% |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.13% |
| KOMP | State Street SPDR S&P Kensho New Economies Composite ETF | 0.09% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.06% |
| IWC | iShares Micro-Cap ETF | 0.05% |
| IBB | iShares Biotechnology ETF | 0.02% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.02% |
| AVSC | Avantis U.S. Small Cap Equity ETF | 0.02% |
| IWN | iShares Russell 2000 Value ETF | 0.02% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.01% |
| RSSL | Global X - Russell 2000 ETF | 0.01% |
| VTWO | Vanguard Russell 2000 ETF | 0.01% |
| IWM | iShares Russell 2000 ETF | 0.01% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.01% |
| UWM | ProShares - Ultra Russell2000 | 0.01% |
| URTY | ProShares - UltraPro Russell2000 | 0.01% |
| VHT | Vanguard Health Care ETF | 0.01% |
| VXF | Vanguard Extended Market ETF | 0.01% |
| FHLC | FIDELITY MSCI HEALTH CARE INDEX ETF | 0.00% |
| SPGM | State Street SPDR Portfolio MSCI Global Stock Market ETF | 0.00% |
| DFSU | Dimensional - US Sustainability Core 1 ETF | 0.00% |
| SMMD | iShares Russell 2500 ETF | 0.00% |
| HDG | ProShares - Hedge Replication ETF | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.00% |
| AVUS | Avantis U.S. Equity ETF | 0.00% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.00% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.00% |
| DFAU | Dimensional - US Core Equity Market ETF | 0.00% |
| DFUS | Dimensional - US Equity Market ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| SCHB | Schwab U.S. Broad Market ETF | 0.00% |
About DNA ETF Exposure
Ginkgo Bioworks Holdings, Inc. (DNA) is held by 49 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 394.5M, DNA is a widely held institutional stock. The stock currently trades at $6.37. Investors can gain exposure to DNA through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold DNA, sorted by portfolio weight.